Flosonics Medical, founded in February 2015, is focused on making a wearable ultrasound monitor to help clinicians with precision fluid management.

Bright Angel Therapeutics, a biotechnology company focused on developing novel antifungal drugs, today announced an extension to their seed financing round, adding funding that will enable continued advancement of their lead program targeting invasive and drug-resistant fungal infections.

Marion Surgical, which is building the world's first Virtual Reality Surgical Simulator, is one of the companies selected by the Canadian Digital Media Network, to join its Soft Landing program.

RetiSpec was selected as the winner of iGan Partners’ annual Pitch to Heal Event.

Canadian manufacturer KA Imaging has managed to overcome the challenge of having soft-tissue differentiation and single exposure featured in the same digital X-ray detector. The company plans to present Reveal™ to the Health Care market next year. Reveal™ is the world’s first portable digital detector capable of separating different energy levels.

Winterlight Labs Inc., a company that is developing a proprietary AI technology to identify possible cognitive or functional changes in patients, has raised $5.6 million in new funding. The funding round was led by Hikma Ventures.

NERv Technology, a medical technology start-up co-founded by two University of Waterloo engineering alumni, topped more than 100,000 applicants to take first place and the $500,000 prize at the Entrepreneurship World Cup in Saudi Arabia.

Amplitude Venture Capital today announced the launch of a CAD $200 million fund to continue its successful investment strategy of building globally competitive Canadian healthcare companies. The Fund is focused on developing platform companies based on outstanding Canadian precision medicine innovation.

Synaptive Medical, a leader in automation and robotics, announced today a strategic commercial expansion into the spinal surgery market. As part of this expansion, Synaptive is also announcing a co-marketing collaboration with Stryker’s Advanced Guidance Technologies business for the company’s robotically controlled digital microscope, Modus V™.

RetiSpec Inc. announced that it has received an award of up to USD $500,000, which includes a direct investment in the company, from the Alzheimer's Drug Discovery Foundation to fund the accelerated development of retinal imaging technology for the early detection of Alzheimer's disease.

NERv Technology Inc., an innovative medtech venture co-founded by a number of University of Waterloo alumni, has secured $1 million CAD in pre-seed funding.

Iris Technologies announced this week that Accelera Medtech Canada had acquired the company and its flagship product - the Iris Monitor - the world's first computer monitors clinically proven to help concussion patients reduce the painful symptoms of light sensitivity when using a computer.

The Lazaridis Institute for the Management of Technology Enterprises has selected 10 of the country’s most promising technology companies to participate in the fifth cohort of the Lazaridis ScaleUp Program. The institute, housed in Wilfrid Laurier University’s Lazaridis School of Business and Economics, supports Canada’s tech sector through research and programming focused on growth and innovation. Its ScaleUp Program helps companies grow globally through mentorship, programming, and access to a global network of experts.

With funding support from Global Affairs Canada, Medtech Canada is inviting Candian medtech companies to apply to receive financial support to attend Arab Health in Dubai, Jan 27-30, 2020.

AmacaThera Inc. is pleased to announce the closing of its US$3.6M seed financing round. A first close of the round was led by Sprout BioVentures/ Viva Biotech with participation from Grey Sky Venture Partners, and the round was recently completed with an investment by Toronto-based Lumira Ventures.

This week, the Globe & Mail reported how RetiSpec's retinal scan has the potential to detect patterns specific to Alzheimer's disease even before symptoms develop using a specialized camera and software that analyzes how light reflects off the back of a person's eye.

Ontario Genomics is pleased to announce that a new round of Genome Canada’s Genomic Applications Partnership Program (GAPP) is now open (Round 18). The program provides a unique opportunity for Receptor organizations to collaborate with an ’omics researcher, and to leverage their R&D investments with public funding.

Application deadline: October 28, 2019

Click here to learn more.

Interface Biologics Inc. (“IBI”), a privately held, commercial stage developer of innovative material science technologies for Medtech and Pharmaceutical applications, is pleased to announce the sale of its surface modification business to Evonik, a German based specialty chemical company with revenues in excess of €13 billion in 2018.

Click here for more information

This week, the Globe & Mail reported that venture-capital investment surged to its strongest first half on record, injecting $2.15-billion into Canadian startups and scale-ups, according to the Canadian Venture Capital & Private Equity Association (CVCA).

iMerciv was accepted into the Fall 2019 Cohort of the Canadian Technology Accelerator in Silicon Valley, which helps high-potential Canadian technology companies access the unique resources of Silicon Valley to grow at a global scale.